Analysts Expect Ocular Therapeutix (OCUL) Stock to Rise 174%


Ocular Therapeutix Inc (OCUL) stock is up 10.24% Tuesday and is higher by more than 22% over the past week. OCUL stock has fallen -50.62% over the last 12 months, and the average rating from Wall Street analysts is a Moderate Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives OCUL stock a score of 57 out of a possible 100.

That score is mainly influenced by a fundamental score of 74. In addition to the average rating from Wall Street analysts, OCUL stock has a mean target price of $9.80. This means analysts expect the stock to climb 173.74% over the next 12 months. OCUL’s score also includes a short-term technical score of 53. The long-term technical score for OCUL is 45.

Click Here to get the full Stock Score Report on Ocular Therapeutix Inc (OCUL).

What’s Happening with OCUL Stock Today

Ocular Therapeutix Inc (OCUL) stock is higher by 10.24% while the S&P 500 has gained 0.27% as of 11:35 AM on Tuesday, Jun 11. OCUL has gained $0.33 from the previous closing price of $3.25 on volume of 580,655 shares. Over the past year the S&P 500 is higher by 4.04% while OCUL has fallen -50.62%. OCUL lost -$1.58 per share in the over the last 12 months.

Symbols: OCUL

You May Also Like